Andrew Feber

Summary

Affiliation: University College London
Country: UK

Publications

  1. doi request reprint Epigenetics Markers of Metastasis and HPV-Induced Tumorigenesis in Penile Cancer
    Andrew Feber
    UCL Cancer Institute, University College London, London, United Kingdom
    Clin Cancer Res 21:1196-206. 2015
  2. pmc Comments on: Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed paraffin-embedded paired tumor and normal tissue
    Christina Thirlwell
    Medical Genomics Laboratory, UCL Cancer Institute, 72, Huntley Street, London WC1E 6BT, UK
    BMC Res Notes 5:631. 2012
  3. pmc Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors
    Andrew Feber
    Medical Genomics, UCL Cancer Institute, University College London, London, United Kingdom
    Genome Res 21:515-24. 2011
  4. pmc ChAMP: 450k Chip Analysis Methylation Pipeline
    Tiffany J Morris
    Medical Genomics, and Statistical Genomics, UCL Cancer Institute, University College London, London WC1E 6BT, UK, CAS MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Shanghai 200031, China and Institute of Environmental Medicine, Karolinska Instytutet, 17177 Stockholm, Sweden
    Bioinformatics 30:428-30. 2014
  5. doi request reprint Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip
    Christina Thirlwell
    Medical Genomics Group, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6BT, UK
    Methods 52:248-54. 2010
  6. pmc Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
    Paul Guilhamon
    Medical Genomics, UCL Cancer Institute, University College London, London, UK
    Nat Commun 4:2166. 2013
  7. pmc Resources for methylome analysis suitable for gene knockout studies of potential epigenome modifiers
    Gareth A Wilson
    Medical Genomics, UCL Cancer Institute, University College London, London, UK
    Gigascience 1:3. 2012
  8. pmc Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner
    Stefan H Stricker
    Department of Cancer Biology, UCL Cancer Institute, University College London, London WC1E 6BT, United Kingdom
    Genes Dev 27:654-69. 2013
  9. doi request reprint Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer
    Pratik M S Gurung
    Division of Surgery and Interventional Science, University College London UCL, London, United Kingdom
    Int J Cancer 136:709-20. 2015

Collaborators

Detail Information

Publications9

  1. doi request reprint Epigenetics Markers of Metastasis and HPV-Induced Tumorigenesis in Penile Cancer
    Andrew Feber
    UCL Cancer Institute, University College London, London, United Kingdom
    Clin Cancer Res 21:1196-206. 2015
    ..Although HPV is known to contribute to tumorigenesis, little is known about the genetic or epigenetic alterations defining penile cancer...
  2. pmc Comments on: Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed paraffin-embedded paired tumor and normal tissue
    Christina Thirlwell
    Medical Genomics Laboratory, UCL Cancer Institute, 72, Huntley Street, London WC1E 6BT, UK
    BMC Res Notes 5:631. 2012
    ..Moreover, we continue to analyse genome-wide methylation data from DNA extracted from FFPE tissue successfully on both the HumMeth27 and 450 K arrays...
  3. pmc Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors
    Andrew Feber
    Medical Genomics, UCL Cancer Institute, University College London, London, United Kingdom
    Genome Res 21:515-24. 2011
    ..This study establishes MeDIP-seq as an effective method to analyze cancer methylomes...
  4. pmc ChAMP: 450k Chip Analysis Methylation Pipeline
    Tiffany J Morris
    Medical Genomics, and Statistical Genomics, UCL Cancer Institute, University College London, London WC1E 6BT, UK, CAS MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Shanghai 200031, China and Institute of Environmental Medicine, Karolinska Instytutet, 17177 Stockholm, Sweden
    Bioinformatics 30:428-30. 2014
    ..Here we present an integrated analysis pipeline offering a choice of the most popular normalization methods while also introducing new methods for calling differentially methylated regions and detecting copy number aberrations...
  5. doi request reprint Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip
    Christina Thirlwell
    Medical Genomics Group, UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6BT, UK
    Methods 52:248-54. 2010
    ..Here, we describe a protocol for the analysis of FFPE samples using the Infinium HumanMethylation27 BeadChip...
  6. pmc Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
    Paul Guilhamon
    Medical Genomics, UCL Cancer Institute, University College London, London, UK
    Nat Commun 4:2166. 2013
    ....
  7. pmc Resources for methylome analysis suitable for gene knockout studies of potential epigenome modifiers
    Gareth A Wilson
    Medical Genomics, UCL Cancer Institute, University College London, London, UK
    Gigascience 1:3. 2012
    ..However, quality control and analysis of MeDIP-seq data have remained to be a challenge...
  8. pmc Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner
    Stefan H Stricker
    Department of Cancer Biology, UCL Cancer Institute, University College London, London WC1E 6BT, United Kingdom
    Genes Dev 27:654-69. 2013
    ..However, in the context of the neural lineage, widespread resetting of GBM-associated epigenetic abnormalities is not sufficient to override the cancer genome...
  9. doi request reprint Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer
    Pratik M S Gurung
    Division of Surgery and Interventional Science, University College London UCL, London, United Kingdom
    Int J Cancer 136:709-20. 2015
    ..36 to 0.78, p = 0.002) but was not prognostic in the cystectomy set. In conclusion, AIMP3 expression is lost in a subset of bladder cancers and is significantly predictive of survival following radiotherapy in MIBC patients. ..